Gene Expression and Alternative Splicing Analysis in a Large-Scale Multiple Sclerosis Study.

Area of Science:

• Neuroimmunology
• Molecular Biology
• Genomics

Background:

• Multiple Sclerosis (MS) is a significant autoimmune neurodegenerative disease impacting millions worldwide.
• Despite extensive research, the precise mechanisms driving MS development and progression remain incompletely understood.
• Understanding molecular alterations in MS is crucial for identifying effective therapeutic strategies.

Purpose of the Study:

• To investigate gene expression patterns and alternative splicing events in post-mortem white matter from MS patients and healthy controls.
• To identify molecular pathways and potential pathological isoforms associated with MS pathogenesis.
• To uncover novel drug targets for Multiple Sclerosis treatment.

Main Methods:

• Analysis of a publicly available RNA-sequencing dataset (GSE138614) from MS patients and control donors.
• Correlation of gene expression levels with tissue inflammation markers.
• Identification of RNA-binding motifs, differentially expressed RNA-binding proteins, and single-nucleotide polymorphisms (SNPs).

Main Results:

• Genes positively correlated with inflammation were enriched in immune and receptor pathways; negatively correlated genes were enriched in nervous system development and metabolism.
• Distinct gene expression profiles were observed between normal-appearing white matter (NAWM) and active MS lesions.
• Identified exon skipping and spontaneous SNPs in key genes like MARCHF1 and UGT8, implicated in autoimmunity and neurodegeneration.

Conclusions:

• The study identified unique genes, pathways, and splicing events contributing to MS pathology.
• Specific genes and splicing alterations in MS white matter offer potential targets for novel therapeutic interventions.
• Further investigation into these findings could lead to improved treatments for Multiple Sclerosis.